Clinical trials
Neuromuscular Diseases trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 5 |
| Terminated | 4 |
| Recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| MarsiBionics | 6 |
| Fulcrum Therapeutics | 3 |
| Scholar Rock, Inc. | 3 |
| Universitat Internacional de Catalunya | 3 |
| PTC Therapeutics | 2 |
| Universidad Católica San Antonio de Murcia | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| ABLE Human Motion S.L. | 1 |
| AstraZeneca | 1 |
| Avidity Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromuscular Diseases | 35 |
| Muscular Dystrophies | 10 |
| Musculoskeletal Diseases | 10 |
| Nervous System Diseases | 8 |
| Muscular Diseases | 7 |
| Cerebral Palsy | 6 |
| Genetic Diseases, Inborn | 6 |
| Muscular Atrophy, Spinal | 6 |
| Muscular Disorders, Atrophic | 6 |
| Muscular Dystrophy, Duchenne | 5 |
Trials
Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.